Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENZALUTAMIDE Cause Product physical issue? 189 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 189 reports of Product physical issue have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.4% of all adverse event reports for ENZALUTAMIDE.

189
Reports of Product physical issue with ENZALUTAMIDE
0.4%
of all ENZALUTAMIDE reports
7
Deaths
19
Hospitalizations

How Dangerous Is Product physical issue From ENZALUTAMIDE?

Of the 189 reports, 7 (3.7%) resulted in death, 19 (10.1%) required hospitalization, and 1 (0.5%) were considered life-threatening.

Is Product physical issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 189 reports have been filed with the FAERS database.

What Other Side Effects Does ENZALUTAMIDE Cause?

Fatigue (8,891) Death (6,680) Malignant neoplasm progression (4,696) Prostatic specific antigen increased (3,731) Asthenia (3,589) Drug ineffective (3,468) Hot flush (3,144) Decreased appetite (3,069) Nausea (2,898) Dizziness (2,776)

What Other Drugs Cause Product physical issue?

SUMATRIPTAN (2,349) TIOTROPIUM (807) ICOSAPENT ETHYL (666) LISDEXAMFETAMINE DIMESYLATE (652) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (387) IBUPROFEN (337) ESTRADIOL\LEVONORGESTREL (305) ESTRADIOL (302) RUXOLITINIB (302) IXAZOMIB (298)

Which ENZALUTAMIDE Alternatives Have Lower Product physical issue Risk?

ENZALUTAMIDE vs EPCORITAMAB ENZALUTAMIDE vs EPCORITAMAB-BYSP ENZALUTAMIDE vs EPERISONE ENZALUTAMIDE vs EPHEDRINE ENZALUTAMIDE vs EPINASTINE

Related Pages

ENZALUTAMIDE Full Profile All Product physical issue Reports All Drugs Causing Product physical issue ENZALUTAMIDE Demographics